Filing Flows

Filing Flows › Ironwood Pharmaceuticals (IRWD) › Next earnings date

Ironwood Pharmaceuticals (IRWD) earnings: beat the estimate

Ironwood Pharmaceuticals (IRWD) reported on Nov 5, 2026 and beat the EPS estimate: $0.36 against $0.31 (+16.1%). Revenue was $133M for Q3 2026, +9% year over year. It beat the EPS estimate in 60% of the quarters on record.

Last result+16.1% vs estimate
Beat rate60%

The last report

Ironwood Pharmaceuticals reported revenue of $133M for the third quarter 2026 (+9% Y/Y), net earnings $59.8M. How it makes money → · Every quarter →

Ironwood Pharmaceuticals: EPS against the estimate, last 5 reportsIronwood Pharmaceuticals: EPS against the estimate, last 5 reportsEstimateReported$0.12$0.24Nov 25$0.01−$0.01Feb 26$0.24$0.24May 26$0.28$0.31Aug 26$0.31$0.36Nov 26
Latest (Nov 26): Estimate $0.31, Reported $0.36.

Ironwood Pharmaceuticals' latest quarter

Ironwood Pharmaceuticals, Q3 2026: revenue $133M (+9% year over year), operating margin 70.0%, net earnings $59.8M, operating cash flow $67.4M. The chart follows the revenue to costs, profit and cash.

Questions

Did Ironwood Pharmaceuticals beat earnings?

Ironwood Pharmaceuticals (IRWD) reported on Nov 5, 2026 and beat the EPS estimate: $0.36 against $0.31 (+16.1%).

When does IRWD report earnings?

The next date is not set yet.

Does Ironwood Pharmaceuticals usually beat earnings?

It beat the consensus EPS estimate in 60% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.